![]() |
Basic Information |
![]() |
Post buying leads |
![]() |
Suppliers |
![]() |
Cas Database |
Name |
10,11-Dihydro-5-(3-dimethylamino-2-methylpropyl)-5h-dibenz (b,f)azepine |
EINECS | N/A |
CAS No. | 739-71-9 | Density | 0.9912 (rough estimate) |
PSA | 6.48000 | LogP | 4.18600 |
Solubility | N/A | Melting Point |
45° |
Formula | C20H26 N2 | Boiling Point | 426.2°C (rough estimate) |
Molecular Weight | 294.44 | Flash Point | 9℃ |
Transport Information | N/A | Appearance | N/A |
Safety | Poison by ingestion, intraperitoneal, subcutaneous, and intravenous routes. Human systemic effects by ingestion: unspecified heart effects. When heated to decomposition it emits toxic fumes of NOx. | Risk Codes | 11-23/24/25-39/23/24/25 |
Molecular Structure |
|
Hazard Symbols | F,T |
Synonyms |
5H-Dibenz[b,f]azepine,5-[3-(dimethylamino)-2-methylpropyl]-10,11-dihydro- (6CI,7CI,8CI); (?à)-Trimipramine;10,11-Dihydro-5-(3-dimethylamino-2-methylpropyl)-5H-dibenz[b,f]azepine; 5-(g-Dimethylamino-b-methylpropyl)-10,11-dihydro-5H-dibenzo[b,f]azepine;5-[3-(Dimethylamino)-2-methylpropyl]-10,11-dihydro-5H-dibenz[b,f]azepine; 7162RP; IL 6001; RP 7162; Rhotrimine; Sapilent; Surmontil; Trimeprimine;Trimeproprimine; Trimipramine; b-Methylimipramine |
Article Data | 9 |
IUPAC Name: 3-(5,6-Dihydrobenzo[b][1]benzazepin-11-yl)-N,N,2-trimethylpropan-1-amine
Molecular Formula: C20H26N2
Molecular Weight: 294.48
Freely Rotating Bonds: 4
Polar Surface Area: 6.48 Å2
Index of Refraction: 1.567
Molar Refractivity: 93.51 cm3
Molar Volume: 286.1 cm3
Polarizability: 37.07 ×10-24 cm3
Surface Tension: 39.1 dyne/cm
Density: 1.029 g/cm3
Flash Point: 183.3 °C
Enthalpy of Vaporization: 66.43 kJ/mol
Boiling Point: 411.8 °C at 760 mmHg
Vapour Pressure: 5.45E-07 mmHg at 25°C
The Cas Register Number of 10,11-Dihydro-5-(3-dimethylamino-2-methylpropyl)-5h-dibenz (b,f)azepine is 739-71-9 .The chemical synonyms of 10,11-Dihydro-5-(3-dimethylamino-2-methylpropyl)-5h-dibenz (b,f)azepine (CAS NO.739-71-9) are 1-(3-Dimethylamino-2-methylpropyl)-4,5-dihydro-2,3:6,7-dibenzazepine ; 3-(10,11-Dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N,2-trimethylpropan-1-amine and Trimipramine . The molecular structure of 10,11-Dihydro-5-(3-dimethylamino-2-methylpropyl)-5h-dibenz (b,f)azepine (CAS NO.739-71-9) is.
10,11-Dihydro-5-(3-dimethylamino-2-methylpropyl)-5h-dibenz (b,f)azepine (CAS NO.739-71-9) is used as pharmaceutical intermediate.
1. | orl-hmn TDLo:18 mg/kg:CVS | PSDTAP Proceedings of the European Society for the Study of Drug Toxicity. 6 (1965),171. | ||
2. | orl-mus LD50:250 mg/kg | BCFAAI Bollettino Chimico Farmaceutico. 102 (1963),753. | ||
3. | ipr-mus LD50:145 mg/kg | CRSBAW Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. 155 (1961),307. | ||
4. | scu-mus LD50:200 mg/kg | BCFAAI Bollettino Chimico Farmaceutico. 102 (1963),753. | ||
5. | ivn-mus LD50:42 mg/kg | CRSBAW Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. 155 (1961),307. |
EPA Genetic Toxicology Program.
Poison by ingestion, intraperitoneal, subcutaneous, and intravenous routes. Human systemic effects by ingestion: unspecified heart effects. When heated to decomposition it emits toxic fumes of NOx.
RIDADR: 3249
HazardClass: 6.1(b)
PackingGroup: III